Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

December 1, 2017Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approves first biosimilar for the treatment of certain breast and stomach cancers

Post navigation

← Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices →
Proudly powered by WordPress